This observation, together with the evidence showing the RAF-mediated inhibition of ASK1 and the interplay between RASSF1A and the MAPK signalling, could suggest another mechanism through which RASSF1A could counteract RAF1 anti-apoptotic activity in melanoma. This evidence concerns the gene MAP3K5 and melanoma.